Penetrance analyses of the complete set of pedigrees using Mendel resulted in a HR of breast cancer by age 70 years equal to 2.81 (95% CI 1.47 to 5.35) for carriers of founder BRCA1 mutations compared to non-carriers. This evidence concerns the gene BRCA1 and breast carcinoma.